Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan and Lansoprazole in Healthy Participants
Condition: Healthy Participants Interventions: Drug: Vonoprazan; Drug: Lansoprazole Sponsor: Phathom Pharmaceuticals, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2021 Category: Research Source Type: clinical trials
Comparison of Vonoprazan-based Versus Lansoprazole-based Triple Therapy, High Dose Dual Therapy, Bismuth and Non-bismuth Quadruple Therapy in the First-line Treatment of Helicobacter Pylori Infection
Condition: H. Pylori Infection Interventions: Drug: (A) T-V14; Drug: (B) T-V7; Drug: (C) D-V14; Drug: (D) HD-V14; Drug: (E) BQ-V14; Drug: (F) RH-V14; Drug: (G) BQ-L14; Drug: (H) T-L14 Sponsor: National Taiwan University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2021 Category: Research Source Type: clinical trials
Efficacy of Tegoprazan Based Bismuth Quadruple Therapy Compared With Bismuth Quadruple Therapy for Helicobacter Pylori Infection: Randomized, Double-blind, Active-Controlled Study
Condition: Helicobacter Pylori Infection Interventions: Drug: Tegoprazan; Drug: Lansoprazole Sponsor: Incheon St.Mary's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2020 Category: Research Source Type: clinical trials
Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection Interventions: Drug: Tegoprazan; Drug: Lansoprazole Sponsor: Incheon St.Mary's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2020 Category: Research Source Type: clinical trials
